TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. 

TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. 

Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

Bpifrance

European Commission

AQUITI Gestion

Soridec

XAnge

Galia Gestion

Leonard Green & Partners

Aquitaine Science Transfer

BNP Paribas Développement

Bristol-Myers Squibb

TreeFrog Therapeutics

TreeFrog Therapeutics is part of the #FrenchTech2030 selection!

Along with 124 other start-ups, we joined this program created by La French Tech which aims to support the world technological leaders of tomorrow!

Many thanks to Bruno Le Maire, Jean-Noël Barrot, Roland Lescure, Sylvie Retailleau, Bruno Bonnell, Clara Chappaz, Nicolas Dufourcq.

#celltherapyforall #france2030


Emmanuel Macron, Bpifrance, Louis FLEURET, Géraldine Leveau, Nicolas Desruelles, Antoine Roson, Maximilien Marek, Emmanuel Dequier, Jean-Pierre Burnouf, Guilhem de Vregille, Laurent Higueret, Elsy Boglioli Hofman, Yann Bubien
French Tech Bordeaux  ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine POLEPHARMA MabDesign Université de Bordeaux Aquitaine Science Transfert (SATT Aquitaine) Région Nouvelle-Aquitaine UNITEC Secretary general for investment France Biotech BIOTECHFINANCES XAnge Bpifrance Large Venture AQUITI Gestion Imagine Institute of Genetic Diseases GALIA GESTION IRDI Capital Investissement CNRS

Meet us next week in #Paris!
 
We are pleased to announce that we will be sponsoring and participating in the 6th Annual FSSCR Meeting.
 
R&D Scientist Caroline Royer and Research Engineer Eddy Quelennec will attend the congress from January 22 to 24, and give a short presentation of TreeFrog Therapeutics.
They will also present the latest job opportunities, so feel free to ask them your questions and all about life as a Froggie!

#celltherapyforall

We are very proud Froggies today as our CEO Frédéric Desdouits is re-elected to the Board of France Biotech, chairing the think tank on #biomanufacturing.

#celltherapyforall

***********************************************************

Nous sommes très fiers aujourd'hui de vous annoncer que notre CEO Frédéric Desdouits est réélu au conseil d'administration de France Biotech. Il présidera le groupe de réflexion sur la #bioproduction.

#celltherapyforall

Pour finir l'année en beauté, les Froggies ont sorti leurs plus beaux pulls moches de Noël!
Bravo à Inês qui a gagné la première place et merci à tous pour ce magnifique défilé 😉

L'occasion pour TreeFrog Therapeutics de vous souhaiter, à toutes et à tous, de joyeuses fêtes de fin d'année! Nous revenons en 2024 plus déterminés que jamais...
 
#voeux #Froggies #celltherapyforall

***********************************************************

Wrapping up 2023 on a high note! The Froggies embraced the Christmas spirit with the Ugly Sweater Day. Congratulations to Inês for winning first place and thank you all for this wonderful fashion show 😉

TreeFrog Therapeutics' teams hope you will have a happy festive season and are excited for what's next in 2024!

#greetings #Froggies #celltherapyforall

To kick off an exciting 2024, some of the TreeFrog Therapeutics' leadership team will be at the J.P. Morgan 42nd annual Healthcare Meeting.
 
Our CEO Frédéric Desdouits, co-founder, Chief Technical Officer and VP US Kévin Alessandri, and Chief Business Officer Daniel Castro will be in #SanFrancisco from January 8th to 11th!
 
They still have some slots available, so do not hesitate to reach out to them directly on LinkedIn.
 
#JPMorgan #celltherapyforall

From December 5th to 7th, some of our talented Analytical team, Lucie Manache-Alberici and Solenn Guilbert, will attend the 5th Cell Therapy Analytical Summit in #Boston, to discuss potency, safety, viability, and sterility across early and late-stage analytical development in oncology and regenerative medicine.  

Please feel free to join them on site and ask them your questions!
 
#celltherapyforall

If imaging and advances in cell therapy technology get you excited, then be sure to attend TreeFrog’s presentation at the Meeting of bio-imaging players in #NouvelleAquitaine (Journée BIPSA-FBI) on November 30.
 
Process Analytical Technologies Project Manager Laura Oudjedi, Research Engineer Anirban Jana and Process & Analytical Technologies Engineer Marilyn LEPLEUX will be there to present TreeFrog Therapeutics' technologies at 9:50 AM, a good opportunity to learn more about us!
 
#BIPSA #Bordeaux #imaging #celltherapyforall

TreeFrog Therapeutics is pleased to publicly announce the appointment of three new Executive Committee members: Jaime Arango Chief Financial Officer, Rachel Mooney Chief Communications Officer and Jens Schröder, MD PhD Chief Medical Officer.

Read the news here: https://lnkd.in/en9VT57J
 
Welcome aboard! 🐸 

#exco #celltherapyforall

[TREEFROG RECRUTE]

🔎 TreeFrog Therapeutics recherche son/sa nouveau/nouvelle Manager Développement de Procédés Upstream à #Pessac en #CDI !

Vous êtes un expert en développement de procédés et vous avez envie de faire évoluer une super équipe ? Et si vous aussi vous participiez à l’aventure TreeFrog ? 
Postulez dès maintenant pour rejoindre la team d’Elisa, Responsable Process Development : https://lnkd.in/eFZ5d-sQ
D’ailleurs, elle donne quelques conseils aux futurs candidats 😊

Rejoignez dès aujourd’hui une entreprise en forte croissance et ses 120 collaborateurs, et apportons ensemble la thérapie cellulaire à des millions de patients !

Vous connaissez quelqu'un qui pourrait être intéressé ? N'hésitez pas à partager !
Plus d’infos sur treefrog.fr 

#celltherapyforall #recrutement #upstreamprocessing #recruiting #hiring #jobsearch #cellculture #processdev #biotech #celltherapyforall

********************************************************
 
[TREEFROG IS HIRING]

🔎 TreeFrog Therapeutics is searching for its new Upstream Process Development Manager in #Pessac (permanent contract)!

Are you a process development expert looking to lead a great team and help them grow? 
Apply now to join Head of Process Development Elisa’s team: https://lnkd.in/eFZ5d-sQ
Checkout the video for her tips to future candidates 😊

If you want to join a fast-growing company with a mission to bring cell therapy to millions of patients, don’t hang about, apply today! 
 
If this is not for you, but you know someone who might be interested, please share this post with them! 
More info on treefrog.fr

#celltherapyforall #recrutement #upstreamprocessing #recruiting #hiring #jobsearch #cellculture #processdev #biotech #celltherapyforall

Congratulations to Fabien Debaecker and thank you to Kobe City Media for the interview with Fabien, Head of TreeFrog Therapeutics, Japan. 

Fabien sat down with the journalists to discuss why TreeFrog Therapeutics chose the City of Kobe for our base in Japan as he explains :
“Kobe is home to the Kobe Medical Industry City with a concentration of world-class institutes, academia and hospitals that promote cutting-edge medical care and is the largest biomedical cluster in Japan….We were very happy to be the first foreign biotech company to move into the Creative Lab for Innovation in Kobe (CLIK )... This was important for TreeFrog as we aim to partner with the best Japanese research centers and businesses to bring cell therapy to millions of patients”. 

https://lnkd.in/etjMQAsA

GenSight Biologics is a biotechnology company focused on developing gene therapies for retinal neurodegenerative diseases.

GenSight Biologics

Prevail Therapeutics is a biotechnology company specializing in developing gene therapies for neurodegenerative diseases.

Prevail Therapeutics

Voyager is a biotechnology company dedicated to developing gene therapies for severe neurological diseases.

Voyager

TreeFrog Therapeutics is a cell therapy biotech company based in Bordeaux, France, focused on advancing a pipeline of allogeneic cell therapies based on human induced pluripotent stem cells (hiPSCs) and developing a breakthrough technology – C-Stem – for scaling up cell therapy manufacturing in bioreactors.

news impact assignment basic	general	Mar 4, 2024 5:46 PM	17775092
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 5:46 PM	6bfc9f4c
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 4, 2024 5:46 PM	7c560105
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 4, 2024 5:46 PM	aef91f3c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

FR:TREEFROG

TreeFrog Therapeutics